Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe)

WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.--(BUSINESS WIRE)--Aug 5, 2009 - Merck & Co., Inc., Schering-Plough Corporation and the companies' cholesterol joint venture, Merck/Schering-Plough Pharmaceuticals (MSP), today announced that they...